Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Login

|

Seminar
LESI Pop-Up Series "The TRIPs COVID-19 Waiver – Revisited"

Website: https://www.lesi.org/events/upcoming-events/2022/11/01/default-calendar/lesi-pop-up-series-the-trips-covid-19-waiver-revisited

The Topic: Given its international community of IP licensing experts, LESI is in a unique position to bring together various perspectives on IP policy issues.  We did so last year as the World Trade Organization (WTO) was considering adoption of a waiver of patent and other relevant IP rights related to the COVID-19 pandemic.   After significant debate, on June 22, 2022 the WTO formally adopted a more limited waiver than what was initially proposed that allowed member countries to provide a waiver under the treaty for the production and supply of COVID-19 vaccines. The language of the waiver also directed the TRIPS Counsel to, within six months, consider further expanding the scope of the waiver to cover patents related to diagnostics and therapeutics – a process which is now underway.

The Format: The debate regarding the role of IP and its impact on pandemic response efforts continues globally. Education is critically important in this debate.  We introduced LESI “Pop-up” classes as short workshops that provide an opportunity to engage in new material, or activities not typically covered in the traditional curriculum.  With this format, interactivity is key. We will lead with a 45-minute panel discussion of experts, followed by a 45-minute interactive, small break-out sessions. In those sessions, the speakers and other experts will lead a conversation where attendees will have an opportunity to share their own views.

Join LESI for this conversation as we reconvene our panel from last year for a discussion of the waiver as adopted, use by member countries and any impacts it has had and WTO considers taking addition steps on this issue.  Our LESI Education Committee and Industry, University & Government Transactions (IGUT) Committee are jointly facilitating this session.

This event is free to participants.